Lawyers and Settlements
Home Page >> Potential Lawsuit >> Invokana Linked with Cardiovascular Injuries and Kidney Failure

Invokana Linked with Cardiovascular Injuries and Kidney Failure


Invokana lawsuits have been filed against Janssen Pharmaceuticals alleging Invokana side effects include an increased risk of kidney problems and cardiovascular problems. Additionally, the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have issued warnings about kidney problems and diabetic ketoacidosis—both of which are serious conditions—potentially linked to Invokana use.

En Español [INVOKANA]

FREE CASE EVALUATION

Send your Invokana claim to a lawyer who will review your claim at NO COST or obligation.Get Legal Help Now

Invokana

Invokana (canagliflozin), is a type 2 diabetes medication and is in a class of drugs known as SGLT2 inhibitors. It works by causing the kidneys to remove sugar from the blood via urine and was first approved by the US Food and Drug Administration (FDA) in 2013. Some diabetes patients may be prescribed Invokamet, which is a diabetes medication combining Invokana with metformin hydrochloride (Glucophage).

Other drugs in the SGLT2 class include dapagliflozin (Forxiga) and empagliflozin (Jardiance), Xigduo XR (dapagliflozin and metformin extended-release) and Glyxambi (empagliflozin and linagliptin).

Invokana Lawsuits

Invokana lawsuits have now been filed against Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, alleging patients suffered serious side effects as a result of the use of Invokana. One such lawsuit (Maddox v. Janssen Pharmaceuticals, et al, case number; 2:16-cv-01189) alleges patients who were prescribed Invokana "have suffered and may continue to suffer severe and permanent personal injuries, including diabetic ketoacidosis, stroke, heart attack, and severe kidney damage."

Maddox's lawsuit alleges the defendants knew or should have known about the risks but failed to adequately warn patients, putting them at risk of diabetic ketoacidosis, cardiovascular problems and kidney damage. Specifically, Maddox argues he developed ketoacidosis and kidney damage less than a year after starting Invokana treatment.

Invokana Ketoacidosis

In May 2015, the FDA warned that Invokana was linked to ketoacidosis, a serious condition in which the body produces high levels of ketones. Patients were warned to watch for signs of ketoacidosis, including difficulty breathing, nausea, vomiting, abdominal pain, confusion and unusual fatigue or sleepiness and seek medical attention if any signs of ketoacidosis occur.

According to the Mayo Clinic, DKA symptoms may also include excessive thirst, frequent urination and even fruity-scented breath. Diabetes patients can typically recognize signs of diabetic ketoacidosis via home blood and urine tests that indicate high blood sugar levels (hyperglycemia) and/or high ketone levels.

The FDA's warning was based on its Adverse Event Reporting System (FAERS), which contained 20 cases of acidosis, ketoacidosis or ketosis in patients treated with SGLT2 inhibitors between March 2013 and June 2014. FDA notes that more Invokana FAERS reports have been received since June 2014. All patients reportedly required hospitalization.

Diabetic ketoacidosis is a serious condition that occurs when insulin levels are too low resulting in excessively high blood sugar levels. The body then burns fat for fuel, resulting in ketones building up, which upsets the blood's chemical balance. A person experiencing DKA may require emergency care and hospitalization to treat the ketoacidosis.

Invokana Adverse Reactions

In March 2015, the FDA requested an update to Invokana's label to warn about the risk of genital mycotic infections (yeast infections) in both males and females. A study presented at the American Diabetes Association (ADA) 2013 Scientific Sessions suggested 10 percent of women taking Invokana experienced a yeast infection compared with three percent of women who took a placebo.

Invokana has reportedly been linked to an increased risk of kidney problems. In 2015, the Institute for Safe Medication Practices warned in its quarterly report that it had identified 457 serious adverse event reports, including kidney failure or impairment, dehydration and fluid imbalances, kidney stones, urinary tract infections and abnormal weight loss.

On February 12, 2016, the European Medicines Agency (EMA) issued recommendations concerning SGLT2 Inhibitors. The agency warned that patients taking such medications should contact healthcare professionals immediately and treatment should be stopped if diabetic ketoacidosis is confirmed.

SGLT2 Inhibitor FDA Warning

In addition to Invokana and Invokamet, the FDA has also issued a warning about SGLT2 inhibitors potentially leading to DKA. The FDA is investigating type 2 diabetes medications including dapagliflozin (Forxiga) and empagliflozin (Jardiance). Additionally, two other SGLT2 inhibitors, Xigduo XR (dapagliflozin and metformin extended-release) and Glyxambi (empagliflozin and linagliptin) are also being investigated.

Invokana Lawsuits

Attorneys are investigating possible Invokana lawsuits. Patients who have suffered adverse events after using Invokana—or people whose loved ones died after suffering an adverse event—may be eligible to file a lawsuit. If you or a loved one has suffered damages or injuries due to Invokana, please click the link below and your complaint will be sent to a Drug and Medical Device lawyer who will evaluate your claim at no cost or obligation.
Last updated on

INVOKANA LEGAL ARTICLES AND INTERVIEWS

Plaintiffs Celebrate Invokana Lawsuit Consolidation
Plaintiffs Celebrate Invokana Lawsuit Consolidation Trenton, NJ: Plaintiffs involved in Invokana lawsuits are celebrating now that at least some lawsuits have been consolidated for pretrial proceedings. The Invokana claims were filed against drug maker Johnson & Johnson and allege the company failed adequately test the drug before releasing it on the market and did not warn consumers about the risks associated with using the diabetes medication [READ MORE]

Judicial Panel Considers Consolidating Invokana Lawsuits
Judicial Panel Considers Consolidating Invokana Lawsuits Charlotte, NC: On December 1, 2016, the US Judicial Panel on Multidistrict Litigation (JPML) considered consolidating Invokana lawsuits for pretrial proceedings. Although a decision has not been issued yet, a response to the motion for consolidation was filed by Janssen Pharmaceuticals and indicates the company is also in favor of consolidating the lawsuits [READ MORE]

Janssen Loses One Invokana Battle
Janssen Loses One Invokana Battle Trenton, NJ: As patients wait to hear if the proposed Invokana multidistrict litigation has been approved, Janssen has been handed a loss in a lawsuit filed against them. The maker of the diabetes drug had filed to have a lawsuit thrown out of Pennsylvania state court, but a judge found the Invokana lawsuit could continue as filed [READ MORE]



READER COMMENTS

Posted by
DON JOHNSON
on
I HAVE BEEN TAKING INVOKANA FOR ABOUT FOUR MONTHS,THE FIRST MONTH WAS GREAT BLOOD SUGARS REALY LOW. THEN IT STOPED WORKING AT ALL, NOW I CAN'T GET THEM DOWN AT ALL ,I TAKE A LOT OF INSULAN AND I JUST CHEKED ABOUT AN HOUR AGO AND WAS 456, I CAN'T IMAGINE WATS GOING ON.

ADD YOUR COMMENT ON THIS ISSUE

Fields marked * are mandatory. Please read our comment guidelines before posting.

*Name:

Note: Your name will be published with your comment.

*Email Address:

Your email will only be used if a response is needed.

*Your Comment:

Are you the defendant or a subject matter expert on this topic with an opposing viewpoint? We'd love to hear your comments here as well, or if you'd like to contact us for an interview please submit your details here.

Request Invokana Legal Help

First name:

Last name:

Email address:

Phone number(s):

Zip/Postal Code:

Describe your complaint:

By submitting this form I agree to the Terms of Service.
There is no cost to submit this form.
I would like to be interviewed by a journalist.
Subscribe to our free weekly newsletter.

Check Claim Status Advertise with us Legal Funding


Related Lawsuits

Legal Services:

Facebook



 
FAQ | TOS | Privacy | Disclaimer | About Us | Contact Us | Press | Advertise | Member Login | Site Map | View Mobile Website

American Bar Association - Proud Member   Better Business Bureau   CAALA   Best of the Web Approved   Public Justice


This work is licensed under a Creative Commons Attribution-NoDerivs 3.0 Unported License © 2001-2017 Online Legal Media. All rights reserved.


Visit other Online Legal Media Websites:

BigClassAction.comCALaborLawNews.com
OnlineLegalMarketing.comHealthEffectsOfAsbestos.com
Get Legal Help